Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jaad.2015.12.020 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Diffuse face and ear hypertrichosis caused by 5% topical minoxidil in an adult woman with spontaneous resolution.
Dermatol Online J
August 2024
Dermatology and Dermatologic Surgery Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Minoxidil is a vasodilator medication known for its ability to promote hair growth. Although it was first introduced as an oral drug to treat hypertension, minoxidil was observed to have the important side-effect of increasing hair growth. This led to the development of a topical formulation as a 2% concentration solution for the treatment of female androgenic alopecia (AGA) and 5% for treating male AGA, which is considered as a first line U.
View Article and Find Full Text PDFA Well-Tolerated Hair Serum Containing New Natural Active Ingredients Reduced Hair Loss and Improved Quality of Life in Women With Chronic Telogen Effluvium: A 16-Week Controlled Study.
J Cosmet Dermatol
December 2024
Centre de Santé Sabouraud, Hôpital Saint-Louis, Paris, France.
Background: Chronic telogen effluvium (CTE) is characterized by hair loss lasting for more than 6 months and severely impairs quality of life (QoL). There is no specific treatment.
Aims: To assess the dermatological tolerance and clinical efficacy of a hair serum containing three plant-derived active ingredients (a Silybum marianum extract, Manganese PCA, and a Lespedeza capitata extract) in women with CTE.
Impact of Persistent Alopecia on Quality of Life in Childhood Cancer and Transplant Survivors.
Pediatr Blood Cancer
February 2025
Harvard Medical School, Boston, Massachusetts, USA.
Background: While alopecia associated with chemotherapy, radiation, or hematopoietic stem-cell transplant (C/R/HSCT) is transient in most children, prior reports indicate nearly one in seven childhood cancer survivors suffer from persistent alopecia after their treatment is completed. The objective of our study was to better characterize the impact of C/R/HSCT-associated persistent alopecia on patient quality of life.
Procedure: A cross-sectional cohort study of patients with a history of C/R/HSCT who were seen at Dana Farber Cancer Institute/Boston Children's Hospital Dermatology from August 2023 to February 2024 for any indication was conducted.
Lipedematous scalp and lipedematous alopecia: a narrative review.
Arch Dermatol Res
October 2024
Department of Dermatology and Venereology, Uşak University Faculty of Medicine, Uşak, Turkey.
Lipedematous scalp (LS) and lipedematous alopecia (LA) are uncommon conditions with an unclear cause. Over the past century, about 115 cases have been documented in the literature. It is unknown if these disorders are indeed so uncommon or if cases that accept the illness as a structural alteration or are asymptomatic make the disease appear more uncommon than it is.
View Article and Find Full Text PDFWoodhouse-sakati syndrome with no reportable MRI findings: a case report.
BMC Neurol
September 2024
Wellington Hospital, HCA Healthcare, 27 Circus Road, London, UK.
Article Synopsis
- Woodhouse-Sakati Syndrome (WSS) is a rare genetic disorder characterized by symptoms like hypogonadism and neurological issues, often starting in adolescence, with under 200 known cases.
- A unique case of WSS was presented with no notable MRI findings, differing from typical reports, and included symptoms like abnormal leg movements, clumsiness, dysarthria, and alopecia.
- The patient underwent successful genetic testing for WSS diagnosis and received treatment, including botulinum toxin injections and deep brain stimulation, resulting in significant improvements in mobility and overall quality of life.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!